Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06155422
What this trial is testing

A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Gang Chen (101199) 670
Testing effectiveness (Phase 2)UnknownNCT03085069
What this trial is testing

Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms Nec+4 more
Jiangsu HengRui Medicine Co., Ltd. 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT05676931
What this trial is testing

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Gilead Sciences 400
Testing effectiveness (Phase 2)UnknownNCT05338957
What this trial is testing

MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.

Who this might be right for
Advanced Malignant Solid Tumors
Shanghai Miracogen Inc. 30
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Large-scale testing (Phase 3)UnknownNCT03975036
What this trial is testing

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

Who this might be right for
Advanced Solid Tumor
Henan Cancer Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07380984
What this trial is testing

PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Ruijin Hospital 47
Early research (Phase 1)UnknownNCT02836834
What this trial is testing

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

Who this might be right for
LymphomaLung Cancer
Shanghai Junshi Bioscience Co., Ltd. 33
Testing effectiveness (Phase 2)UnknownNCT04782804
What this trial is testing

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Fudan University 30
Early research (Phase 1)Study completedNCT03945604
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC

Who this might be right for
Triple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 32
Testing effectiveness (Phase 2)Looking for participantsNCT05841472
What this trial is testing

Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung Cancer
CrystalGenomics, Inc. 60
Early research (Phase 1)UnknownNCT05649761
What this trial is testing

A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 61
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04204577
What this trial is testing

The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Chinese PLA General Hospital 90
Large-scale testing (Phase 3)Active Not RecruitingNCT02362594
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,019
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)UnknownNCT04150575
What this trial is testing

A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy

Who this might be right for
Cervical Cancer
Shanghai Henlius Biotech 21
Testing effectiveness (Phase 2)Looking for participantsNCT05859750
What this trial is testing

AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Akeso 78
Testing effectiveness (Phase 2)Looking for participantsNCT06787911
What this trial is testing

Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Yu Wang 14
Testing effectiveness (Phase 2)Ended earlyNCT02767934
What this trial is testing

Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaMinimal Residual DiseaseRecurrent Acute Lymphoblastic Leukemia+1 more
University of Washington 12
Next Page